Exelixis Inc Surpasses Analyst Price Target; What Does It Mean for Investors?
In recent trading, Exelixis Inc (Symbol: EXEL) shares have moved past the average analyst 12-month target price of $28.28, selling at $28.50 per share. When a stock reaches this target, analysts typically respond in two ways: either by adjusting their valuation downward or by increasing their target price. Their reaction often hinges on the company’s recent performance and developments that have led to the stock’s price rise.
The average target price for Exelixis Inc comes from 18 analysts within the Zacks coverage universe. However, this average does not tell the full story. Some analysts have lower price targets, including one who estimates it will fall to $23.00. Conversely, another analyst has set an ambitious target of $33.00. The standard deviation among these estimates is $2.396.
The average price target is meant to reflect a “wisdom of crowds” approach, where the combined insights of many analysts provide a broader perspective than any single expert’s opinion. With EXEL trading above the average target price, investors are now prompted to reassess the company’s outlook. This raises an important question: is $28.28 merely a stepping stone to even higher valuations, or has the stock price increased too far, warranting caution and possible profit-taking?
| Recent EXEL Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| » | Current | 1 Month Ago | 2 Month Ago | 3 Month Ago |
| Strong buy ratings: | 13 | 13 | 14 | 14 |
| Buy ratings: | 1 | 1 | 1 | 1 |
| Hold ratings: | 6 | 5 | 5 | 5 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.65 | 1.58 | 1.55 | 1.55 |
The average rating mentioned in the table ranges from 1 to 5, where 1 indicates a Strong Buy and 5 denotes a Strong Sell. This report utilized data provided by Zacks Investment Research via Quandl.com. For the latest Zacks research report on EXEL, click here — FREE.
10 ETFs With Most Upside To Analyst Targets »
Also see:
• Funds Holding NSPI
• IT MACD
• Institutional Holders of ROIA
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
